Enanta Pharmaceuticals
ENTA
#7691
Rank
โ‚น20.28 B
Marketcap
โ‚น957.13
Share price
-1.48%
Change (1 day)
26.23%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2024 (TTM): โ‚น5.99 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น6.06 Billion. In 2023 the company made a revenue of โ‚น6.12 Billion a decrease over the revenue in the year 2022 that were of โ‚น6.79 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น5.99 B-2.21%
2023 โ‚น6.12 B-9.78%
2022 โ‚น6.79 B-1.84%
2021 โ‚น6.92 B-6.9%
2020 โ‚น7.43 B-44.52%
2019 โ‚น13.39 B-19.63%
2018 โ‚น16.66 B100.05%
2017 โ‚น8.33 B144.08%
2016 โ‚น3.41 B-61.03%
2015 โ‚น8.76 B11.16%
2014 โ‚น7.88 B2407.61%
2013 โ‚น0.31 B-91.66%
2012 โ‚น3.76 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น4.638 T 76,331.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.395 T 121,767.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น871.74 B 14,265.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.268 T 86,724.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.000 T 65,818.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.211 T 69,299.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland